What challenges could arise in making advanced cancer drugs like AstraZeneca’s accessible and affordable in India after regulatory approval?
AstraZeneca has received approval to market a new cancer drug in India. I am curious about the obstacles that patients and the healthcare system might face in ensuring widespread access to such medicines.